Skip to main content

GOLDMAN SACHS GROUP INC

Position in DYN — Dyne Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in DYN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$31,240,092
-$13,419,123 QoQ
Shares Held
1,723,116
-24.5% QoQ
Ownership
1.21%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority Sole 99.46289164513591.ToString("F0")% Shared 0.ToString("F0")% None 0.5371083548640951.ToString("F0")%

Common Shares in DYN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,297,038,010 across 364 Biotechnology names. DYN ranks #70 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DYN

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $31,240,092 1,723,116
2025-12-31 $44,659,215 2,283,191
2025-09-30 $24,037,719 1,900,215
2025-06-30 $12,761,016 1,340,443
2025-03-31 $10,406,506 994,886
2024-12-31 $14,812,241 628,703
2024-09-30 $24,083,784 670,484
2024-06-30 $73,958,981 2,095,749
2024-03-31 $47,158,288 1,661,088
2023-12-31 $15,438,267 1,160,772
2023-09-30 $13,512,952 1,508,142
2023-06-30 $22,607,200 2,009,529
2023-03-31 $17,216,063 1,494,450
2022-12-31 $9,689,436 836,017
2022-09-30 $5,049,138 397,570
2022-06-30 $453,715 66,043
2022-03-31 $757,288 78,557
2021-12-31 $1,006,106 84,618
2021-09-30 $637,728 39,269
2021-06-30 $3,832,351 182,146
2021-03-31 $1,592,026 102,513
2020-12-31 $939,099 44,719
2020-09-30 $3,593,557 177,987